0
     

Report Added
Report already added
Heart Failure Therapeutics Market - Global Outlook and Forecast 2022-2028

Heart Failure Therapeutics Market - Global Outlook and Forecast 2022-2028

Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night.A limited ability to exercise is also a common feature. Chest pain, including angina, does not typically occur due to heart failure.
This report contains market size and forecasts of Heart Failure Therapeutics in Global, including the following market information:

Global Heart Failure Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Heart Failure Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Heart Failure Therapeutics include Bayer, Cynokinetics, Les Laboratoires Servier, Merck & Co., Novartis, Procoralan, Bristol-Myers Squibb Company, Cardiorentis AG and CVie Therapeutics Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Heart Failure Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Heart Failure Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Heart Failure Therapeutics Market Segment Percentages, by Type, 2021 (%)
Diagnosis
Prognosis
Treatment Options and Treatment Algorithm
Global Heart Failure Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Heart Failure Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Medical Research Organization
Global Heart Failure Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Heart Failure Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Heart Failure Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Heart Failure Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Cynokinetics
Les Laboratoires Servier
Merck & Co.
Novartis
Procoralan
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Orion Corporation
PhaseBio Pharmaceuticals
Market Segment by Product Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Heart Failure Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Heart Failure Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Heart Failure Therapeutics Overall Market Size
2.1 Global Heart Failure Therapeutics Market Size: 2021 VS 2028
2.2 Global Heart Failure Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Heart Failure Therapeutics Players in Global Market
3.2 Top Global Heart Failure Therapeutics Companies Ranked by Revenue
3.3 Global Heart Failure Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Heart Failure Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Heart Failure Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Heart Failure Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Heart Failure Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Heart Failure Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Heart Failure Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Diagnosis
4.1.3 Prognosis
4.1.4 Treatment Options and Treatment Algorithm
4.2 By Type - Global Heart Failure Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Heart Failure Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Heart Failure Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Heart Failure Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Heart Failure Therapeutics Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Medical Research Organization
5.2 By Application - Global Heart Failure Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Heart Failure Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Heart Failure Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Heart Failure Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Heart Failure Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Heart Failure Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Heart Failure Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Heart Failure Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Heart Failure Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Heart Failure Therapeutics Revenue, 2017-2028
6.3.2 US Heart Failure Therapeutics Market Size, 2017-2028
6.3.3 Canada Heart Failure Therapeutics Market Size, 2017-2028
6.3.4 Mexico Heart Failure Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Heart Failure Therapeutics Revenue, 2017-2028
6.4.2 Germany Heart Failure Therapeutics Market Size, 2017-2028
6.4.3 France Heart Failure Therapeutics Market Size, 2017-2028
6.4.4 U.K. Heart Failure Therapeutics Market Size, 2017-2028
6.4.5 Italy Heart Failure Therapeutics Market Size, 2017-2028
6.4.6 Russia Heart Failure Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Heart Failure Therapeutics Market Size, 2017-2028
6.4.8 Benelux Heart Failure Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Heart Failure Therapeutics Revenue, 2017-2028
6.5.2 China Heart Failure Therapeutics Market Size, 2017-2028
6.5.3 Japan Heart Failure Therapeutics Market Size, 2017-2028
6.5.4 South Korea Heart Failure Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Heart Failure Therapeutics Market Size, 2017-2028
6.5.6 India Heart Failure Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Heart Failure Therapeutics Revenue, 2017-2028
6.6.2 Brazil Heart Failure Therapeutics Market Size, 2017-2028
6.6.3 Argentina Heart Failure Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Heart Failure Therapeutics Revenue, 2017-2028
6.7.2 Turkey Heart Failure Therapeutics Market Size, 2017-2028
6.7.3 Israel Heart Failure Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Heart Failure Therapeutics Market Size, 2017-2028
6.7.5 UAE Heart Failure Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Heart Failure Therapeutics Major Product Offerings
7.1.4 Bayer Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Bayer Key News
7.2 Cynokinetics
7.2.1 Cynokinetics Corporate Summary
7.2.2 Cynokinetics Business Overview
7.2.3 Cynokinetics Heart Failure Therapeutics Major Product Offerings
7.2.4 Cynokinetics Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Cynokinetics Key News
7.3 Les Laboratoires Servier
7.3.1 Les Laboratoires Servier Corporate Summary
7.3.2 Les Laboratoires Servier Business Overview
7.3.3 Les Laboratoires Servier Heart Failure Therapeutics Major Product Offerings
7.3.4 Les Laboratoires Servier Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Les Laboratoires Servier Key News
7.4 Merck & Co.
7.4.1 Merck & Co. Corporate Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. Heart Failure Therapeutics Major Product Offerings
7.4.4 Merck & Co. Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Merck & Co. Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Heart Failure Therapeutics Major Product Offerings
7.5.4 Novartis Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Procoralan
7.6.1 Procoralan Corporate Summary
7.6.2 Procoralan Business Overview
7.6.3 Procoralan Heart Failure Therapeutics Major Product Offerings
7.6.4 Procoralan Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Procoralan Key News
7.7 Bristol-Myers Squibb Company
7.7.1 Bristol-Myers Squibb Company Corporate Summary
7.7.2 Bristol-Myers Squibb Company Business Overview
7.7.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Major Product Offerings
7.7.4 Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Bristol-Myers Squibb Company Key News
7.8 Cardiorentis AG
7.8.1 Cardiorentis AG Corporate Summary
7.8.2 Cardiorentis AG Business Overview
7.8.3 Cardiorentis AG Heart Failure Therapeutics Major Product Offerings
7.8.4 Cardiorentis AG Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Cardiorentis AG Key News
7.9 CVie Therapeutics Limited
7.9.1 CVie Therapeutics Limited Corporate Summary
7.9.2 CVie Therapeutics Limited Business Overview
7.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Major Product Offerings
7.9.4 CVie Therapeutics Limited Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.9.5 CVie Therapeutics Limited Key News
7.10 Orion Corporation
7.10.1 Orion Corporation Corporate Summary
7.10.2 Orion Corporation Business Overview
7.10.3 Orion Corporation Heart Failure Therapeutics Major Product Offerings
7.10.4 Orion Corporation Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Orion Corporation Key News
7.11 PhaseBio Pharmaceuticals
7.11.1 PhaseBio Pharmaceuticals Corporate Summary
7.11.2 PhaseBio Pharmaceuticals Business Overview
7.11.3 PhaseBio Pharmaceuticals Heart Failure Therapeutics Major Product Offerings
7.11.4 PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.11.5 PhaseBio Pharmaceuticals Key News
7.12 Market Segment by Product Type
7.12.1 Market Segment by Product Type Corporate Summary
7.12.2 Market Segment by Product Type Business Overview
7.12.3 Market Segment by Product Type Heart Failure Therapeutics Major Product Offerings
7.12.4 Market Segment by Product Type Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.12.5 Market Segment by Product Type Key News
7.13 B-Blockers
7.13.1 B-Blockers Corporate Summary
7.13.2 B-Blockers Business Overview
7.13.3 B-Blockers Heart Failure Therapeutics Major Product Offerings
7.13.4 B-Blockers Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.13.5 B-Blockers Key News
7.14 Calcium Channel Blockers
7.14.1 Calcium Channel Blockers Corporate Summary
7.14.2 Calcium Channel Blockers Business Overview
7.14.3 Calcium Channel Blockers Heart Failure Therapeutics Major Product Offerings
7.14.4 Calcium Channel Blockers Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.14.5 Calcium Channel Blockers Key News
7.15 Cardiac Glycosides
7.15.1 Cardiac Glycosides Corporate Summary
7.15.2 Cardiac Glycosides Business Overview
7.15.3 Cardiac Glycosides Heart Failure Therapeutics Major Product Offerings
7.15.4 Cardiac Glycosides Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.15.5 Cardiac Glycosides Key News
7.16 Diuretics
7.16.1 Diuretics Corporate Summary
7.16.2 Diuretics Business Overview
7.16.3 Diuretics Heart Failure Therapeutics Major Product Offerings
7.16.4 Diuretics Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.16.5 Diuretics Key News
7.17 Morphine
7.17.1 Morphine Corporate Summary
7.17.2 Morphine Business Overview
7.17.3 Morphine Heart Failure Therapeutics Major Product Offerings
7.17.4 Morphine Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.17.5 Morphine Key News
7.18 Vasodilators/Nitrates
7.18.1 Vasodilators/Nitrates Corporate Summary
7.18.2 Vasodilators/Nitrates Business Overview
7.18.3 Vasodilators/Nitrates Heart Failure Therapeutics Major Product Offerings
7.18.4 Vasodilators/Nitrates Heart Failure Therapeutics Revenue in Global Market (2017-2022)
7.18.5 Vasodilators/Nitrates Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Heart Failure Therapeutics Market Opportunities & Trends in Global Market
Table 2. Heart Failure Therapeutics Market Drivers in Global Market
Table 3. Heart Failure Therapeutics Market Restraints in Global Market
Table 4. Key Players of Heart Failure Therapeutics in Global Market
Table 5. Top Heart Failure Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Heart Failure Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Heart Failure Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Heart Failure Therapeutics Product Type
Table 9. List of Global Tier 1 Heart Failure Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Heart Failure Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Heart Failure Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Heart Failure Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Heart Failure Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Heart Failure Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Heart Failure Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Heart Failure Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Heart Failure Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Heart Failure Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Heart Failure Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Heart Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Heart Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Heart Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Heart Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Heart Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Heart Failure Therapeutics Product Offerings
Table 32. Bayer Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Cynokinetics Corporate Summary
Table 34. Cynokinetics Heart Failure Therapeutics Product Offerings
Table 35. Cynokinetics Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Les Laboratoires Servier Corporate Summary
Table 37. Les Laboratoires Servier Heart Failure Therapeutics Product Offerings
Table 38. Les Laboratoires Servier Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co. Corporate Summary
Table 40. Merck & Co. Heart Failure Therapeutics Product Offerings
Table 41. Merck & Co. Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Heart Failure Therapeutics Product Offerings
Table 44. Novartis Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Procoralan Corporate Summary
Table 46. Procoralan Heart Failure Therapeutics Product Offerings
Table 47. Procoralan Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Company Corporate Summary
Table 49. Bristol-Myers Squibb Company Heart Failure Therapeutics Product Offerings
Table 50. Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Cardiorentis AG Corporate Summary
Table 52. Cardiorentis AG Heart Failure Therapeutics Product Offerings
Table 53. Cardiorentis AG Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. CVie Therapeutics Limited Corporate Summary
Table 55. CVie Therapeutics Limited Heart Failure Therapeutics Product Offerings
Table 56. CVie Therapeutics Limited Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Orion Corporation Corporate Summary
Table 58. Orion Corporation Heart Failure Therapeutics Product Offerings
Table 59. Orion Corporation Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. PhaseBio Pharmaceuticals Corporate Summary
Table 61. PhaseBio Pharmaceuticals Heart Failure Therapeutics Product Offerings
Table 62. PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Market Segment by Product Type Corporate Summary
Table 64. Market Segment by Product Type Heart Failure Therapeutics Product Offerings
Table 65. Market Segment by Product Type Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. B-Blockers Corporate Summary
Table 67. B-Blockers Heart Failure Therapeutics Product Offerings
Table 68. B-Blockers Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Calcium Channel Blockers Corporate Summary
Table 70. Calcium Channel Blockers Heart Failure Therapeutics Product Offerings
Table 71. Calcium Channel Blockers Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Cardiac Glycosides Corporate Summary
Table 73. Cardiac Glycosides Heart Failure Therapeutics Product Offerings
Table 74. Cardiac Glycosides Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. Diuretics Corporate Summary
Table 76. Diuretics Heart Failure Therapeutics Product Offerings
Table 77. Diuretics Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 78. Morphine Corporate Summary
Table 79. Morphine Heart Failure Therapeutics Product Offerings
Table 80. Morphine Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 81. Vasodilators/Nitrates Corporate Summary
Table 82. Vasodilators/Nitrates Heart Failure Therapeutics Product Offerings
Table 83. Vasodilators/Nitrates Heart Failure Therapeutics Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Heart Failure Therapeutics Segment by Type in 2021
Figure 2. Heart Failure Therapeutics Segment by Application in 2021
Figure 3. Global Heart Failure Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Heart Failure Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Heart Failure Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Heart Failure Therapeutics Revenue in 2021
Figure 8. By Type - Global Heart Failure Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Heart Failure Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Heart Failure Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Heart Failure Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Heart Failure Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Heart Failure Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Heart Failure Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Heart Failure Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Heart Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cynokinetics Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Les Laboratoires Servier Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co. Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Procoralan Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cardiorentis AG Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. CVie Therapeutics Limited Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Orion Corporation Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Market Segment by Product Type Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. B-Blockers Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Calcium Channel Blockers Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Cardiac Glycosides Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Diuretics Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Morphine Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Vasodilators/Nitrates Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Heart Failure Therapeutics Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027